Unravelling the druggability and immunological roles of the SOCS-family proteins DOI Creative Commons
Dylan M. Lynch,

Beth Forrester,

Thomas Webb

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Ноя. 29, 2024

The Suppressor of Cytokine Signalling (SOCS) protein family play a critical role in cytokine signalling and regulation the JAK/STAT pathway with functional consequences to immune response. Members this are implicated multiple different cascades that drive autoimmune diseases cancer, through their binding phosphotyrosine modified proteins as well ubiquitination activity part Cullin5 RING E3 ligases. Here we review SOCS members CISH SOCS1-SOCS7, focus on complex immunity. interactome network is discussed, intricate mechanisms which alter manage system assessed. We offer structural insights into how engage interacting partners native substrates at protein-protein interaction level. describe knowledge has enabled drug discovery efforts date propose strategies for therapeutic intervention using small molecules, either via direct inhibition or leveraging ligase targeted degradation.

Язык: Английский

Microglial-mediated immune mechanisms in autoimmune uveitis: Elucidating pathogenic pathways and targeted therapeutics DOI
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta

и другие.

Journal of Neuroimmunology, Год журнала: 2024, Номер 395, С. 578433 - 578433

Опубликована: Авг. 14, 2024

Язык: Английский

Процитировано

3

Targeting the JAK-STAT pathway in colorectal cancer: mechanisms, clinical implications, and therapeutic potential DOI Creative Commons
Penghui Li, Di Huang

Frontiers in Cell and Developmental Biology, Год журнала: 2024, Номер 12

Опубликована: Ноя. 26, 2024

Colorectal cancer (CRC) remains one of the most prevalent and fatal malignancies worldwide, consistently ranking among top three in terms incidence mortality. Despite notable advancements early detection therapeutic interventions, survival outcomes for advanced-stage CRC are still dismal, largely due to issues such as drug resistance metastasis. Recent research has increasingly implicated JAK-STAT signaling pathway a pivotal contributor pathogenesis. This evolutionarily conserved plays key role transmitting extracellular signals nucleus, thereby modulating gene expression involved numerous fundamental biological processes. In CRC, dysregulation is frequently observed strongly associated with tumor progression, including processes cellular proliferation, apoptosis, metastasis, immune evasion, sustenance stem cells. Given its integral advancement, gained recognition viable target. Extensive evidence from preclinical clinical models supports efficacy safety targeting components pathway, presenting new possibilities patients particularly addressing enhancing treatment outcomes. review offers detailed exploration focusing on regulatory mechanisms CRC-related malignancies. Moreover, it examines association between protein expression, features, prognosis, potential management.

Язык: Английский

Процитировано

2

Manipulating immune activity of macrophages: a materials and mechanics perspective DOI
Abigail J. Clevenger, Aakanksha Jha, Erika Moore

и другие.

Trends in biotechnology, Год журнала: 2024, Номер unknown

Опубликована: Авг. 1, 2024

Язык: Английский

Процитировано

2

Rutin alleviates psoriasis‐related inflammation in keratinocytes by regulating the JAK2/STAT3 signaling DOI Creative Commons

Panhong Wu,

Yonghui Liu,

Hanxue Zhai

и другие.

Skin Research and Technology, Год журнала: 2024, Номер 30(8)

Опубликована: Авг. 1, 2024

Abstract Background Psoriasis is a chronic inflammatory skin disease that can cause systemic inflammation in various organs. Rutin has been suggested to fight psoriasis, but the signaling pathways by which it works need be explored. Materials and methods HaCaT cells co‐stimulated with interleukin (IL)‐17, IL‐22, tumor necrosis factor‐alpha (TNF‐α), IL‐1α, oncostatin M (M5) were used as an vitro cell model of psoriasis. The proliferation viability determined 5‐ethynyl‐2′‐deoxyuridine counting assays. Relative mRNA levels IL‐6, TNF‐α, chemokines (CXCL1 CXCL2), anti‐microbial peptides (S100A7 S100A8) detected reverse transcriptase‐quantitative PCR. Release IL‐6 TNF‐α from was measured enzyme‐linked immunosorbent assay. Keratin1, Keratin5, p‐JAK2, p‐STAT3 protein estimated western blotting. Molecular docking predicted binding sites for STAT3. Results treatment undercut M5‐urged increase boost cells. Moreover, M5 stimulation mediated upregulation CXCL1, CXCL2, S100A7, S100A8 partially reversed after treatment. In addition, induced downregulation Keratin1 Keratin5 proteins well p‐JAK2 attenuated response treatment, manifesting inhibited M5‐promoted aberrant differentiation impaired M5‐mediated activation JAK2/STAT3 discovered residues GLN326 ASP334 STAT3 might bind Rutin. Conclusion blocked signaling, thus attenuating psoriasis‐related anomalous keratinocytes.

Язык: Английский

Процитировано

1

Identification of functional enhancer variants associated with type I diabetes in CD4+ T cells DOI Creative Commons

Arpit Mishra,

Ajay Jajodia,

Eryn Weston

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Июнь 14, 2024

Type I diabetes is an autoimmune disease mediated by T-cell destruction of β cells in pancreatic islets. Currently, there no known cure, and treatment consists daily insulin injections. Genome-wide association studies twin have indicated a strong genetic heritability for type implicated several genes. As most strongly associated variants are noncoding, still lack identification functional and, therefore, likely causal variants. Given that many these reside enhancer elements, we tested 121 CD4+ with T1D. We found four to be through massively parallel reporter assays. Three the weaken activity, while fourth strengthens activity. link their cognate genes using 3D genome architecture or eQTL data validate them CRISPR editing. Validated target include CLEC16A SOCS1. While been previously 1 other diseases, show enhancers controlling expression harbor These variants, may act as diabetic

Язык: Английский

Процитировано

0

Unravelling the druggability and immunological roles of the SOCS-family proteins DOI Creative Commons
Dylan M. Lynch,

Beth Forrester,

Thomas Webb

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Ноя. 29, 2024

The Suppressor of Cytokine Signalling (SOCS) protein family play a critical role in cytokine signalling and regulation the JAK/STAT pathway with functional consequences to immune response. Members this are implicated multiple different cascades that drive autoimmune diseases cancer, through their binding phosphotyrosine modified proteins as well ubiquitination activity part Cullin5 RING E3 ligases. Here we review SOCS members CISH SOCS1-SOCS7, focus on complex immunity. interactome network is discussed, intricate mechanisms which alter manage system assessed. We offer structural insights into how engage interacting partners native substrates at protein-protein interaction level. describe knowledge has enabled drug discovery efforts date propose strategies for therapeutic intervention using small molecules, either via direct inhibition or leveraging ligase targeted degradation.

Язык: Английский

Процитировано

0